Non-invasive heart valve screening device and method

A method of screening a heart of a patient for heart valve disease, comprising:

• determining peak blood flow velocity within the heart using a hand-held echo velocity monitoring device held by a user against the patient;
• comparing the peak blood flow velocity to a first screening threshold blood flow velocity value;
• if the peak blood flow velocity is below the first screening threshold blood flow velocity value, then providing a first visual indicia through a visual display comprising a green light, the first screening threshold blood flow velocity value indicating a mild risk velocity threshold for heart valve disease and the patient is not provided with additional heart valve disease assessment and analysis using equipment other than the hand-held echo velocity monitoring device;
• if the peak blood flow velocity exceeds the first screening threshold blood flow velocity value, then comparing the peak blood flow velocity to a second screening threshold blood flow velocity value;
• if the peak blood flow velocity matches or exceeds the second screening threshold blood flow velocity value and is below a third screening threshold blood flow velocity value, then providing a second visual indicia through the visual display comprising a yellow light, the second screening threshold blood flow velocity value indicating a moderate risk velocity threshold for heart valve disease;
• if the peak blood flow velocity exceeds the second screening threshold blood flow velocity value, then comparing the peak blood flow velocity to the third screening threshold blood flow velocity value;
• if the peak blood flow velocity matches or exceeds the third screening threshold blood flow velocity value, then providing a third visual indicia through the visual display comprising a red light, the third screening threshold blood flow velocity value indicating a high risk velocity threshold for heart valve disease and providing a recommendation via the hand-held echo velocity monitoring device that the patient receives the additional heart valve disease assessment and analysis using equipment other than the hand-held echo velocity monitoring device;
• wherein the first screening threshold blood flow velocity value is 2.5 m/s;
• wherein the second screening threshold blood flow velocity value is 3.0 m/s;
• and
• wherein the third screening threshold blood flow velocity value is 4.0 m/s.